Andrew C. Karlinski’s Chemours CC Stock Holding History

Andrew C. Karlinski’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-60	Closed	-$1K	–	26
2022 Q3	$1K	Hold	60	–	–	﹤0.01%	244
2022 Q2	$2K	Hold	60	–	–	﹤0.01%	249
2022 Q1	$2K	Buy	+60	New	+$1.88K	﹤0.01%	247

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Andrew C. Karlinski's CC Position: Q4 2022 in Review

Andrew C. Karlinski sold out of Chemours (CC) in Q4 2022, closing a stake of 60 shares — an estimated $1K sold.

Andrew C. Karlinski first reported a position in CC in Q1 2022 and held it in 3 quarters. The position peaked at $2K in Q2 2022. 474 funds tracked by Wall St. Rank hold CC as of Q4 2022.

Andrew C. Karlinski reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
Andrew C. Karlinski sold 60 Chemours shares in Q4 2022, an estimated $1K.
Andrew C. Karlinski first reported a position in Chemours in Q1 2022 and held it in 3 quarters.
Andrew C. Karlinski's Chemours position peaked at $2K in Q2 2022.
474 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on Andrew C. Karlinski's 13F filing for Q4 2022.